$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000155837022014652 Filed on September 27, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$27.66M	$27.45M	$96.67M
YoY Change	26.3%	16.89%	47.29%
Cost Of Revenue	$9.623M	$12.61M	$44.39M
YoY Change	1.93%	-2.52%	21.83%
Gross Profit	$18.03M	$14.84M	$52.28M
YoY Change	44.77%	40.68%	79.05%
Gross Profit Margin	65.2%	54.07%	54.08%
Selling, General & Admin	$17.42M	$17.40M	$69.88M
YoY Change	-0.51%	-12.95%	25.22%
% of Gross Profit	96.63%	117.21%	133.66%
Research & Development	$1.064M	$3.697M	$14.44M
YoY Change	-49.24%	-22.4%	156.78%
% of Gross Profit	5.9%	24.91%	27.62%
Depreciation & Amortization	$2.328M	$2.246M	$10.25M
YoY Change	-13.04%	-304.37%	11.41%
% of Gross Profit	12.91%	15.13%	19.61%
Operating Expenses	$19.69M	$21.95M	$163.8M
YoY Change	-50.98%	1.06%	86.04%
Operating Profit	-$1.653M	-$7.104M	-$111.6M
YoY Change	-94.03%	-36.38%	89.5%
Interest Expense	-$1.100M	-$787.0K	-$862.0K
YoY Change	2650.0%	59.29%	-57.95%
% of Operating Profit
Other Income/Expense, Net	-$1.228M	$999.0K	$1.278M
YoY Change	374.13%	-86.01%	52.14%
Pretax Income	-$2.881M	-$17.70M	-$110.3M
YoY Change	-89.7%	-5.54%	90.04%
Income Tax	$0.00	$0.00	-$110.0K
% Of Pretax Income
Net Earnings	-$2.881M	-$17.70M	-$110.2M
YoY Change	-89.66%	-6.83%	89.01%
Net Earnings / Revenue	-10.42%	-64.49%	-113.97%
Basic Earnings Per Share	-$0.06		-$3.39
Diluted Earnings Per Share	-$0.06	-$492.3K	-$3.75
COMMON SHARES
Basic Shares Outstanding	62.43M	38.57M	29.40M
Diluted Shares Outstanding	50.36M		29.40M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.81M	$19.36M	$19.36M
YoY Change	-40.93%	-61.01%	-61.01%
Cash & Equivalents	$23.81M	$19.36M	$19.36M
Short-Term Investments
Other Short-Term Assets	$785.0K	$633.0K	$8.008M
YoY Change	-34.31%	-39.02%	-27.66%
Inventory	$12.87M	$10.85M	$10.85M
Prepaid Expenses	$9.024M	$7.375M
Receivables	$27.90M	$21.71M	$21.71M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$74.42M	$59.93M	$59.93M
YoY Change	-16.39%	-43.05%	-43.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.648M	$6.296M	$6.296M
YoY Change	-33.49%	-27.66%	-27.66%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles	$69.11M	$70.63M
YoY Change	-17.12%	-17.35%
Long-Term Investments
YoY Change
Other Assets	$829.0K	$766.0K	$766.0K
YoY Change	78.28%	64.73%	64.73%
Total Long-Term Assets	$75.59M	$77.69M	$77.69M
YoY Change	-45.5%	-51.57%	-51.57%
TOTAL ASSETS
Total Short-Term Assets	$74.42M	$59.93M	$59.93M
Total Long-Term Assets	$75.59M	$77.69M	$77.69M
Total Assets	$150.0M	$137.6M	$137.6M
YoY Change	-34.13%	-48.2%	-48.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.67M	$10.99M	$10.99M
YoY Change	56.31%	-42.94%	-42.94%
Accrued Expenses	$41.43M	$44.19M	$35.95M
YoY Change	-23.81%	-13.86%	-27.36%
Deferred Revenue	$100.0K	$400.0K
YoY Change	-50.0%	100.0%
Short-Term Debt	$8.087M	$3.813M	$3.813M
YoY Change	78.92%	-51.94%	-51.94%
Long-Term Debt Due	$925.0K	$96.00K	$96.00K
YoY Change	-94.4%	-99.42%	-99.42%
Total Short-Term Liabilities	$73.20M	$64.44M	$64.44M
YoY Change	-25.3%	-41.12%	-41.12%
LONG-TERM LIABILITIES
Long-Term Debt	$13.56M	$14.28M	$14.28M
YoY Change	8705.19%	7832.78%	7832.78%
Other Long-Term Liabilities	$9.330M	$12.81M	$12.81M
YoY Change	2824.76%	3508.45%	-30.69%
Total Long-Term Liabilities	$9.330M	$12.81M	$27.09M
YoY Change	2824.76%	3508.45%	45.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.20M	$64.44M	$64.44M
Total Long-Term Liabilities	$9.330M	$12.81M	$27.09M
Total Liabilities	$96.09M	$91.53M	$91.53M
YoY Change	-17.32%	-28.55%	-28.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$291.4M	-$288.5M
YoY Change	41.32%	61.81%
Common Stock	$345.3M	$334.6M
YoY Change	8.69%	5.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.91M	$46.09M	$46.09M
YoY Change
Total Liabilities & Shareholders Equity	$150.0M	$137.6M	$137.6M
YoY Change	-34.13%	-48.2%	-48.2%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$2.881M	-$17.70M	-$110.2M
YoY Change	-89.66%	-6.83%	89.01%
Depreciation, Depletion And Amortization	$2.328M	$2.246M	$10.25M
YoY Change	-13.04%	-304.37%	11.41%
Cash From Operating Activities	-$9.100M	-$7.095M	-$28.80M
YoY Change	139.47%	12.91%	10.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$42.00K	-$41.00K	$70.00K
YoY Change	-216.67%	-49.38%	-275.0%
Cash From Investing Activities	$42.00K	-$41.00K	-$3.248M
YoY Change	-148.84%	-98.31%	16.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.56M	-1.117M	1.530M
YoY Change	-348.11%	-109.45%	-94.95%
NET CHANGE
Cash From Operating Activities	-9.100M	-7.095M	-28.80M
Cash From Investing Activities	42.00K	-41.00K	-3.248M
Cash From Financing Activities	13.56M	-1.117M	1.530M
Net Change In Cash	4.451M	-8.253M	-30.54M
YoY Change	-147.65%	-365.54%	-2047.77%
FREE CASH FLOW
Cash From Operating Activities	-$9.100M	-$7.095M	-$28.80M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3346000
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7197000
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5140000
CY2022	us-gaap	Depreciation Depreciation	1600000
CY2021	us-gaap	Depreciation Depreciation	600000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	100000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-100000
CY2021Q4	dei	Entity Public Float EntityPublicFloat	38200000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27490412
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38578825
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29397504
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16746679
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.39
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.48
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27490412
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38578825
CY2021	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2022	aytu	Accounts Receivable Credit Terms Low End Of Range AccountsReceivableCreditTermsLowEndOfRange	P40D
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#AssetImpairmentCharges
CY2022	aytu	Debt Instrument Prepayment Option Period Of Notice Required DebtInstrumentPrepaymentOptionPeriodOfNoticeRequired	P5D
CY2022Q1	us-gaap	Derivative Liability Valuation Technique Extensible List DerivativeLiabilityValuationTechniqueExtensibleList	http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38247
CY2022	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOPHARMA, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0883144
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	373 Inverness ParkwaySuite 206
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Englewood
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
CY2022	dei	City Area Code CityAreaCode	720
CY2022	dei	Local Phone Number LocalPhoneNumber	437-6580
CY2021	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	683000
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.0001
CY2022	dei	Trading Symbol TradingSymbol	AYTU
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62432727
CY2022	dei	Auditor Firm AuditorFirmId	166
CY2022	dei	Auditor Name AuditorName	Plante & Moran, PLLC
CY2022	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19360000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49649000
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	252000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21712000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28176000
CY2022Q2	us-gaap	Inventory Net InventoryNet	10849000
CY2021Q2	us-gaap	Inventory Net InventoryNet	16339000
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7375000
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9780000
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	633000
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1038000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	59929000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	105234000
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3025000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5140000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3271000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3563000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	70632000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	85464000
CY2022Q2	us-gaap	Goodwill Goodwill	0
CY2021Q2	us-gaap	Goodwill Goodwill	65802000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	766000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	465000
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	77694000
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	160434000
CY2022Q2	us-gaap	Assets Assets	137623000
CY2021Q2	us-gaap	Assets Assets	265668000
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	10987000
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	19255000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12810000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18482000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44187000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57234000
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3813000
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7934000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	96000
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	16668000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5359000
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8347000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	64442000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	109438000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14279000
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	180000
CY2022Q2	us-gaap	Liabilities Liabilities	91531000
CY2021Q2	us-gaap	Liabilities Liabilities	128100000
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38578825
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27490412
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	4000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	3000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	334560000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	315864000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288472000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178299000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	46092000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	137568000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	137623000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	265668000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96669000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65632000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	44386000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	36432000
CY2022	us-gaap	Gross Profit GrossProfit	52283000
CY2021	us-gaap	Gross Profit GrossProfit	29200000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14439000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5623000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38713000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30308000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31167000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25500000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2919000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4886000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75458000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12825000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4067000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6009000
CY2022	us-gaap	Operating Expenses OperatingExpenses	163844000
CY2021	us-gaap	Operating Expenses OperatingExpenses	88070000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-111561000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-58870000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-862000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2050000
CY2022	aytu	Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod	1760000
CY2021	aytu	Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod	4459000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	169000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1569000
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	211000
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1278000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	840000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110283000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58030000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-110000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	259000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110173000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58289000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29397504
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16746679
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.48
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	137568000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5248000
CY2022	aytu	Stock Issued During Period Value New Issues Issuance Costs StockIssuedDuringPeriodValueNewIssuesIssuanceCosts	1048000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11653000
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000
CY2022	aytu	Stock Issued During Period Value Milestone Payments StockIssuedDuringPeriodValueMilestonePayments	1425000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	379000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110173000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46092000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	95015000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3574000
CY2021	aytu	Stock Issued During Period Value New Issues Issuance Costs StockIssuedDuringPeriodValueNewIssuesIssuanceCosts	3371000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	41680000
CY2021	aytu	Stock Issued During Period Value Acquisitions Issuance Costs StockIssuedDuringPeriodValueAcquisitionsIssuanceCosts	130000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	53103000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1058000
CY2021	aytu	Adjustments To Additional Paid In Capital Estimated Fair Value Of Replacement Equity Awards AdjustmentsToAdditionalPaidInCapitalEstimatedFairValueOfReplacementEquityAwards	432000
CY2021	aytu	Stock Issued During Period Value Contingent Value Rights Payouts StockIssuedDuringPeriodValueContingentValueRightsPayouts	1000000
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58289000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	137568000
CY2022	us-gaap	Profit Loss ProfitLoss	-110173000
CY2021	us-gaap	Profit Loss ProfitLoss	-58289000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10251000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9201000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75458000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12825000
CY2022	aytu	Issuance Of Stock For Milestone Payments IssuanceOfStockForMilestonePayments	1425000
CY2021	aytu	Issuance Of Stock For Milestone Payments IssuanceOfStockForMilestonePayments	0
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5248000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3574000
CY2022	aytu	Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod	1760000
CY2021	aytu	Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod	4459000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-126000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-44000
CY2022	aytu	Write Off Of Deferred Debt Issuance Cost Net WriteOffOfDeferredDebtIssuanceCostNet	-193000
CY2021	aytu	Write Off Of Deferred Debt Issuance Cost Net WriteOffOfDeferredDebtIssuanceCostNet	1569000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-69000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	608000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	2186000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	7332000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-211000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	4000
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	38000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6533000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1544000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1299000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2786000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2228000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-157000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7681000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3245000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13292000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	771000
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-50000
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	332000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28823000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25964000
CY2022	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	3178000
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	15722000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	15520000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2341000
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	70000
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-40000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3248000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2782000
CY2022	aytu	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	11694000
CY2021	aytu	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	40148000
CY2022	aytu	Payments For Fixed Payment Arrangement PaymentsForFixedPaymentArrangement	4409000
CY2021	aytu	Payments For Fixed Payment Arrangement PaymentsForFixedPaymentArrangement	6088000
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	152236000
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	51206000
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	156357000
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	53979000
CY2022	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	16101000
CY2021	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	968000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	15000000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	0
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	526000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7000
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1530000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30314000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30541000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1568000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49901000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48333000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19360000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49901000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19360000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49649000
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	252000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19360000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49901000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3148000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1249000
CY2022	aytu	Warrants Issued WarrantsIssued	3177000
CY2021	aytu	Warrants Issued WarrantsIssued	1628000
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	54000
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1058000
CY2021	aytu	Contingent Value Rights Payout ContingentValueRightsPayout	1000000
CY2021	aytu	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	53103000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	104322000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	88700000
CY2021	aytu	Estimated Fair Value Of Replacement Equity Awards EstimatedFairValueOfReplacementEquityAwards	432000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	aytu	Number Of Product Candidates In Development NumberOfProductCandidatesInDevelopment	2
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19400000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110200000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58300000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288500000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178300000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28800000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26000000.0
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of estimates</span><i style="font-style:italic;white-space:pre-wrap;">. </i>The preparation of financial statements and footnotes requires the use of management estimates, judgments and assumptions. Actual results may differ from estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation; revenue recognition, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances; allowance for doubtful accounts; inventory impairment; determination of right-of-use assets and lease liabilities; valuation of financial instruments, intangible assets, long-lived assets, and goodwill; purchase price allocations, and the depreciable lives of long-lived assets; accruals for contingent liabilities; and determination of the income tax provision, deferred taxes and valuation allowance. </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Prior Period Reclassification</span><i style="font-style:italic;">.</i> Certain prior year amounts in the consolidated balance sheets, statements of earnings and statements of cash flows have been reclassified to conform to the current year presentation, including a reclassification made in the presentation of the U.S. Food and Drug Administration (the “FDA”) fees for commercialized products. This was previously included in general and administrative expenses and is currently recorded as a component of cost of sales on the condensed consolidated statements of operations. These reclassifications did not impact operating results or cash flows for the year ended June 30, 2022 and 2021 or the Company’s financial position as of June 30, 2022 or June 30, 2021.</p>
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19400000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49900000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10724000
CY2022Q2	us-gaap	Inventory Net InventoryNet	10849000
CY2021Q2	us-gaap	Inventory Net InventoryNet	16339000
CY2022	aytu	Inventory Write Down And Impairment InventoryWriteDownAndImpairment	4200000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000000.0
CY2020Q2	aytu	Cash Discount Reserve CashDiscountReserve	1300000
CY2021Q2	aytu	Cash Discount Reserve CashDiscountReserve	1200000
CY2020Q2	aytu	Chargebacks Reserve ChargebacksReserve	1200000
CY2021Q2	aytu	Chargebacks Reserve ChargebacksReserve	1000000.0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit </span><span style="font-style:italic;font-weight:bold;">Risk</span><i style="font-style:italic;">. </i>Financial instruments that potentially subject the Company to credit risk concentrations consist of cash, cash equivalents and accounts receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company maintains deposits in financial institutions in excess of federally insured limits. The Company periodically monitors the credit quality of the financial institutions with which it invests and believes that the Company is not exposed to significant credit risk due to the financial position of those institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is also subject to credit risk from accounts receivable related to product sales. The Company’s customers, sometimes referred to as partners or customers, are primarily large wholesale distributors that resell the Company’s products to retailers. The loss of one or more of these large customers could have a material adverse effect on the Company’s business, operating results or financial condition. The Company does not charge interest or require collateral related to its accounts receivable. Credit terms are generally <span style="-sec-ix-hidden:Hidden_4EquCwcFc0GVnICnLPAulw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">forty</span></span> to sixty days. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table presents customers that contributed more than 10% of gross revenue and accounts receivable<i style="font-style:italic;">:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage of gross revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage of accounts receivable</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="13" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:51.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:51.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:51.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:51.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">% </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:51.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;"></span></p>
CY2022	aytu	Accounts Receivable Credit Terms High End Of Range AccountsReceivableCreditTermsHighEndOfRange	P60D
CY2021	aytu	Inventory Write Down And Impairment InventoryWriteDownAndImpairment	7300000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Advertising Expense AdvertisingExpense	13600000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	15200000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10546525
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3422389
CY2021	aytu	Number Of Product Portfolios NumberOfProductPortfolios	3
CY2022	aytu	Number Of Product Portfolios NumberOfProductPortfolios	3
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96669000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65632000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96669000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65632000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1012000
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3025000
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1814000
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2269000
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1838000
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	5446000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	6152000
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2421000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1299000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	476000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	152000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	109000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	73000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	21000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	14000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6000
CY2022	us-gaap	Lease Cost LeaseCost	1538000
CY2021	us-gaap	Lease Cost LeaseCost	612000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3271000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3563000
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	256000
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	329000
CY2022Q2	aytu	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	3527000
CY2021Q2	aytu	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	3892000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1227000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	940000
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	96000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	102000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2090000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2624000
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	84000
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	180000
CY2022Q2	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	3497000
CY2021Q2	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	3846000
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M17D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M1D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M23D
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M19D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0748
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0662
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0643
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0641
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6074000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5934000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5683000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5653000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	38602000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68032000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1016000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	467000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	15000
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	5000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	102000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	25000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1436000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	105000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1378000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	87000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	749000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	90000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	46000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3699000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	192000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	382000
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	12000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3317000
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	180000
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	7800000
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	7100000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4900000
CY2020Q2	us-gaap	Goodwill Goodwill	28090000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	37712000
CY2021Q2	us-gaap	Goodwill Goodwill	65802000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	65802000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	91620000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16530000
CY2022Q2	aytu	Finite Lived Intangible Assets Accumulated Impairment FiniteLivedIntangibleAssetsAccumulatedImpairment	7058000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68032000
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P13Y4M6D
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	94220000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16530000
CY2022Q2	aytu	Finite Lived Intangible Assets Accumulated Impairment FiniteLivedIntangibleAssetsAccumulatedImpairment	7058000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	70632000
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P13Y4M6D
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	91620000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8756000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82864000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	94220000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8756000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	85464000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6086000
CY2022Q2	aytu	Accrued Saving Offers AccruedSavingOffers	12711000
CY2021Q2	aytu	Accrued Saving Offers AccruedSavingOffers	20148000
CY2022Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	9468000
CY2021Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	8689000
CY2022Q2	aytu	Return Reserve ReturnReserve	5770000
CY2021Q2	aytu	Return Reserve ReturnReserve	6367000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4765000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5939000
CY2022Q2	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	7817000
CY2021Q2	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	12346000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3656000
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3745000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44187000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57234000
CY2022Q2	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Liability BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationLiability	396000
CY2021Q2	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Liability BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationLiability	12057000
CY2022Q2	aytu	Fixed Payment Arrangements FixedPaymentArrangements	13051000
CY2021Q2	aytu	Fixed Payment Arrangements FixedPaymentArrangements	9458000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3317000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3564000
CY2022Q2	aytu	Contingent Value Rights Liabilities Fair Value Disclosure ContingentValueRightsLiabilitiesFairValueDisclosure	578000
CY2021Q2	aytu	Contingent Value Rights Liabilities Fair Value Disclosure ContingentValueRightsLiabilitiesFairValueDisclosure	1395000
CY2022Q2	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	827000
CY2021Q2	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	355000
CY2022Q2	us-gaap	Other Liabilities OtherLiabilities	18169000
CY2021Q2	us-gaap	Other Liabilities OtherLiabilities	26829000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5359000
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8347000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12810000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18482000
CY2020Q1	aytu	Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum	16000000.0
CY2020Q1	aytu	Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Shares Maximum ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableSharesMaximum	470000
CY2020	aytu	Stock Issued During Period Shares Contingent Value Rights Payouts StockIssuedDuringPeriodSharesContingentValueRightsPayouts	123820
CY2021	aytu	Stock Issued During Period Shares Contingent Value Rights Payouts StockIssuedDuringPeriodSharesContingentValueRightsPayouts	103190
CY2022Q2	aytu	Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum	5000000.0
CY2022Q2	aytu	Contingent Value Rights Liabilities Fair Value Disclosure ContingentValueRightsLiabilitiesFairValueDisclosure	600000
CY2021Q2	aytu	Contingent Value Rights Liabilities Fair Value Disclosure ContingentValueRightsLiabilitiesFairValueDisclosure	1400000
CY2022	aytu	Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentValueRightsGainLossForChangeInFairValueDuringPeriod	800000
CY2021	aytu	Contingent Value Rights Gain Loss For Change In Fair Value During Period ContingentValueRightsGainLossForChangeInFairValueDuringPeriod	3200000
CY2022	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Gain Loss For Change In Fair Value During Period BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationGainLossForChangeInFairValueDuringPeriod	-500000
CY2021	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Gain Loss For Change In Fair Value During Period BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationGainLossForChangeInFairValueDuringPeriod	-1700000
CY2022	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Accretion Expense BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationAccretionExpense	100000
CY2021	aytu	Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Accretion Expense BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationAccretionExpense	400000
CY2022Q1	aytu	Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity	3500000
CY2022Q1	aytu	Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity	1000000.0
CY2022Q1	aytu	Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity	3500000
CY2022	aytu	Legal And Other Fees LegalAndOtherFees	100000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	400000
CY2022Q1	aytu	Debt Instrument Interest Payment Term DebtInstrumentInterestPaymentTerm	P18M
CY2022Q1	aytu	Debt Instrument Interest Payment Extension Term DebtInstrumentInterestPaymentExtensionTerm	P6M
CY2022Q1	aytu	Interest Only Period Further Extension Term InterestOnlyPeriodFurtherExtensionTerm	P6M
CY2022Q1	aytu	Debt Instrument Term Of Trailing Months Revenue DebtInstrumentTermOfTrailingMonthsRevenue	P12M
CY2022Q1	aytu	Debt Instrument Prepayment Fee Percentage DebtInstrumentPrepaymentFeePercentage	0.030
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	600000
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee	400000
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1659
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	900000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	15000000
CY2022Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	638000
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1443000
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	180000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	14375000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	96000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14279000
CY2022Q2	aytu	Long Term Debt And Finance Lease Liability Maturity Year One LongTermDebtAndFinanceLeaseLiabilityMaturityYearOne	96000
CY2022Q2	aytu	Long Term Debt And Finance Lease Liability Maturity Year Two LongTermDebtAndFinanceLeaseLiabilityMaturityYearTwo	8418000
CY2022Q2	aytu	Long Term Debt And Finance Lease Liability Maturity Year Three LongTermDebtAndFinanceLeaseLiabilityMaturityYearThree	7304000
CY2022Q2	aytu	Long Term Debt And Finance Lease Liability Gross LongTermDebtAndFinanceLeaseLiabilityGross	15818000
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1443000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	96000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14279000
CY2021Q2	aytu	Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue	9458000
CY2022	aytu	Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityGainLossIncludedInEarnings	1148000
CY2022	aytu	Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Issuances FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityIssuances	7645000
CY2022	aytu	Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilitySettlements	5200000
CY2022Q2	aytu	Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue	13051000
CY2022	aytu	Contingent Consideration Other Than From Business Combination Liability Reversed In Period ContingentConsiderationOtherThanFromBusinessCombinationLiabilityReversedInPeriod	9100000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	400000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-91000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-26000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	43000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-117000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	243000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-110000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	259000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23159000
CY2022	aytu	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Provision Benefit Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateProvisionBenefitPercent	-0.2100
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12185000
CY2021	aytu	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Provision Benefit Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateProvisionBenefitPercent	-0.2100
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	601000
CY2022	aytu	Effective Income Tax Rate Reconciliation State Income Taxes Net Of Federal Benefit Percent EffectiveIncomeTaxRateReconciliationStateIncomeTaxesNetOfFederalBenefitPercent	0.0055
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2461000
CY2021	aytu	Effective Income Tax Rate Reconciliation State Income Taxes Net Of Federal Benefit Percent EffectiveIncomeTaxRateReconciliationStateIncomeTaxesNetOfFederalBenefitPercent	-0.0424
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	273000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0027
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	43000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0007
CY2022	aytu	Income Tax Reconciliation Contingent Consideration IncomeTaxReconciliationContingentConsideration	-155000
CY2022	aytu	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	-0.0014
CY2021	aytu	Income Tax Reconciliation Contingent Consideration IncomeTaxReconciliationContingentConsideration	-667000
CY2021	aytu	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	-0.0115
CY2022	aytu	Effective Income Tax Rate Reconciliation Covered Employees Deduction Limitation Amount EffectiveIncomeTaxRateReconciliationCoveredEmployeesDeductionLimitationAmount	76000
CY2022	aytu	Effective Income Tax Rate Reconciliation Covered Employees Deduction Limitation Percent EffectiveIncomeTaxRateReconciliationCoveredEmployeesDeductionLimitationPercent	0.0008
CY2021	aytu	Effective Income Tax Rate Reconciliation Covered Employees Deduction Limitation Amount EffectiveIncomeTaxRateReconciliationCoveredEmployeesDeductionLimitationAmount	235000
CY2021	aytu	Effective Income Tax Rate Reconciliation Covered Employees Deduction Limitation Percent EffectiveIncomeTaxRateReconciliationCoveredEmployeesDeductionLimitationPercent	0.0040
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	9733000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.0883
CY2021	aytu	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	160000
CY2021	aytu	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0.0028
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12472000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1131
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14483000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2496
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0001
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	651000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0113
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-110000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0009
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	259000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0045
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	114443000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	106712000
CY2022Q2	aytu	Deferred Tax Assets Accrued Rebates DeferredTaxAssetsAccruedRebates	5944000
CY2021Q2	aytu	Deferred Tax Assets Accrued Rebates DeferredTaxAssetsAccruedRebates	8412000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2773000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2330000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	817000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1507000
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2423000
CY2021Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2115000
CY2022Q2	aytu	Deferred Tax Assets Interest DeferredTaxAssetsInterest	2975000
CY2021Q2	aytu	Deferred Tax Assets Interest DeferredTaxAssetsInterest	2064000
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1177000
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1704000
CY2022Q2	aytu	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	799000
CY2021Q2	aytu	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	1031000
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1301000
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1526000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	132652000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	127401000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	128966000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	116494000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3686000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10907000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2717000
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9396000
CY2022Q2	aytu	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	308000
CY2021Q2	aytu	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1009000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	788000
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	745000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3813000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11150000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	127000
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	243000
CY2022	aytu	Deferred Tax Liabilities Net Decrease During Period Goodwill Impairment DeferredTaxLiabilitiesNetDecreaseDuringPeriodGoodwillImpairment	100000
CY2022	aytu	Income Tax Benefit Decrease In Deferred Tax Liabilities Net IncomeTaxBenefitDecreaseInDeferredTaxLiabilitiesNet	100000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	129000000.0
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	116500000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9800000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11500000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11537000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	12017000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1704000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	482000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9833000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11537000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000.0
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000.0
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38578825
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27490412
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	109588
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.52
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y25D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15569
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.98
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13642
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.65
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	80377
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.61
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	54649
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.58
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M7D
CY2022Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	80377
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	16.61
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2022Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	54649
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	20.58
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.81
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5248000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3574000
CY2022	aytu	Number Of Employee Benefit Plan NumberOfEmployeeBenefitPlan	2
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96669000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65632000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110173000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58289000
CY2022Q2	us-gaap	Assets Assets	137623000
CY2021Q2	us-gaap	Assets Assets	265668000

Files In Submission

Name	View Source	Status
0001558370-22-014652-index-headers.html	Edgar Link	pending
0001558370-22-014652-index.html	Edgar Link	pending
0001558370-22-014652.txt	Edgar Link	pending
0001558370-22-014652-xbrl.zip	Edgar Link	pending
aytu-20220630.xsd	Edgar Link	pending
aytu-20220630x10k.htm	Edgar Link	pending
aytu-20220630x10k001.jpg	Edgar Link	pending
aytu-20220630xex21d1.htm	Edgar Link	pending
aytu-20220630xex23d1.htm	Edgar Link	pending
aytu-20220630xex31d1.htm	Edgar Link	pending
aytu-20220630xex31d2.htm	Edgar Link	pending
aytu-20220630xex32d1.htm	Edgar Link	pending
aytu-20220630xex4d9.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
aytu-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aytu-20220630_lab.xml	Edgar Link	unprocessable
aytu-20220630_def.xml	Edgar Link	unprocessable
aytu-20220630_pre.xml	Edgar Link	unprocessable
aytu-20220630x10k_htm.xml	Edgar Link	completed
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R153.htm	Edgar Link	pending
R154.htm	Edgar Link	pending
R155.htm	Edgar Link	pending
R156.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2022 Q3 Form 10-K Financial Statement

#000155837022014652 Filed on September 27, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2022 Q3 Form 10-K Financial Statement

#000155837022014652 Filed on September 27, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu